HAVCR2 and Bone marrow hypocellularity: In this study, we aimed to explore a novel treatment method of TIM‐3(+) NK or TIM‐3(−) NK cell infusion in combination with immunosuppressive therapy for bone marrow failure (BMF)/aplastic anemia (AA) mice.